The Effect of Laser Therapy Along With Mediterranean Diet Versus Mediterranean Diet Only on Older Adults With Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial Laser Therapy and Mediterranean Diet in Older Adults With Non-Alcoholic Fatty Liver Disease
Journal of Lasers in Medical Sciences,
Vol. 12 (2021),
13 Bahman 2021
,
Page e39
Abstract
Introduction: Obesity is the major pathogenesis of non-alcoholic fatty liver disease (NAFLD). The combination of low-level laser therapy (LLLT) and Mediterranean diet (MD) is a new approach for improving liver function.
Methods: 60 obese older adults (65-75 years old) with NAFLD were randomly assigned equally to two groups: a study group and a control group. The study group received LLLT and MD, while the control group followed MD only. These findings evaluated the changes in the level of liver enzymes, serum lipid profile, and anthropometric measurements (body mass index [BMI] and waist circumference [WC]) after 12 weeks of intervention.
Results: Both study and control groups showed a significant reduction in the levels of liver enzymes, serum lipid profile, BMI, and WC (P<0.001 and P <0.01 respectively); however, the study group showed more significant results compared to the control group (P<0.01).
Conclusion: LLLT and MD may be considered as a treatment approach for NAFLD in older adults to improve their liver function, control dyslipidemia, and help in losing weight.
- Laser therapy; Liver function; Mediterranean diet; Non-alcoholic fatty liver.
How to Cite
References
Angulo P. Non alcoholic fatty liver disease. N Engl J Med. 2002; 346:1221–31. doi:10.1056/NEJMra011775
Mahmoud HS, Helal MM, Hassan MH, Sherif MF. Correlation between anthropometric measures, lipid profile and serum adiponectin and steatosis in nondiabetic nonalcoholic fatty liver disease. Br J Med Med Res. 2015; 7:771–778. doi: 10.9734/BJMMR/2015/16594
Mohamed AA, Gohary KK, Mashad GM, Hammoda GE, Abdallah AM, Khattab RA. et al. Interleukin 10, thyroid status and ferritin are non-invasive prognostic biomarkers for diagnosis of fatty liver disease in children. J Int Res Med Pharm Sci. 2016; 8:85–93.
Maher JJ, Leon P, Ryan JC. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology. 2008; 48:670–678. doi: 10.1002/hep.22399
Esteghamati A., Jamali A., Khalilzadeh O., Noshad S., Khalili M., Zandieh A.,et al.. Metabolic syndrome is linked to a mild elevation in liver aminotransferases in diabetic patients with undetectable non-alcoholic fatty liver disease by ultrasound. Diabetol Metab Syndr. 2010; 2:65. https://doi.org/10.1186/s13098-020-00570-y.13
Koga M, Saito H, Mukai M, Saibara T, Kasayama S. Serum dehydroepiandrosteronesulphate levels in patients with non-alcoholic fatty liver disease. Intern Med. 2011; 50:1657–1661.
Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc .2009; 41: 459-471. doi: 10.1249/MSS.0b013e3181949333
Chin SH, Kahathuduwa CN, Binks M. Physical activity and obesity: What we know and what we need to know. Obes Rev. 2016;1226-1244. doi:10.1111/obr.12460.
Romagnolo DF, Selmin OI. Mediterranean Diet and Prevention of Chronic Diseases. Nutr Today. 2017; 52: 208–222. doi: 10.1016/j.semcancer.2017.06.011
Sofi F, Abbate R, Gensini GF, Casini A . Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis. Am J Clin Nutr. 2010;92: 1189–1196. doi: 10.1136/bmj.a1344
Marventano S, Kolacz P, Castellano S, Galvano F, Buscemi S, Mistretta A, Grosso G. Areviewofrecent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular diseases, cancer, and depressive disorders: Does the ratio really matter? Int J Food Sci Nutr. 2015. doi: 10.3109/09637486.2015.1077790
Rosenbaum M, Prieto V, Hellmer J, Boschmann M, Krueger J, Leibel RL et al. An exploratory investigation of the morphology and biochemistry of cellulite. Plast Reconstr Surg. 1998;101(7):1934–1939. doi: 10.1097/00006534-199806000-00025.
Nestor MS, Newburger J, Zarraga MB. Body contouring using 635-nm low level laser therapy. Semin Cutan Med Surg. 2013;32(1):35–40.
Jackson FR, Roche GC, Wisler K. Reduction in cholesterol and triglyceride serum levels following low-level laser irradiation: A noncontrolled, nonrandomized pilot study. Am J Cosmet Surg. 2010;27(4):177–184. 35.
Aquino AE Jr, Sene-Fiorese M, Paolillo FR, Duarte FO, Oishi JC, Pena AA et al. Low-level laser therapy (LLLT) combined with swimming training improved the lipid profile in rats fed with high-fat diet. Lasers Med Sci. 2013; 28: 1271-1280. doi:10.1007/s10103-012-1223-z.
Sanyal, D. Mukherjee, P., Raychaudhuri, M., Ghosh,S., Mukherjee.S. & Chowdhury,S . Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J Endocrinol Metab. 2015; 19(5): 597–601. .doi: 10.4103/2230-8210.163172.
Hegazy M, Mostafa A. Liver Ultrasound Scanning in the Detection of Hepatic Steatosis and Fibrosis in NASH Patients. Egypt J Intern Med. 2012; 24 27-31. doi: 10.7123/01.EJIM.0000419544.37462.5f
Mader U, Martin BW, Schutz Y, Marti B. “Validity of four short physical activity questionnaires in middle-aged persons.” Med Sci Sports Exerc. 2006; 38: 1255-66. doi: 10.1249/01.mss.0000227310.18902.28.
Croghan IT, Hurt RT, Schroeder DR, , Fokken SC, Jensen MD, Clark MM et al, Low- level laser therapy for weight reduction: a randomized pilot study. Laser Med Sci. 2020;35:663-75. doi: 10.1007/s10103-019-02867-5
Be´dard A, Riverin M, Dodin S, Corneau L, Lemieux S. Sex differences in the impact of the Mediterranean diet on cardiovascular risk profile. Br J Nutr. 2012; 108: 1428–1434. doi: 10.1017/S0007114511006969.
Lichtenstein AH, Rasmussen H, Yu WW, Epstein SR, Russell R M "Modified MyPyramid for Older Adults." J Nutr. 2008; 138: 1 5-11. doi: 10.1093/jn/138.1.5.
Harris JA, Benedict FG. A Biometric Study of Human Basal Metabolism. Natl Acad Sci U S A. 1918. 4 (12): 370–373. doi: 10.1073/pnas.4.12.370
Avci P, Nyame TT, Gupta GK, Sadasivam M, Hamblin MR. Low-level laser therapy for fat layer reduction: a comprehensive review. Lasers Surg Med. 2013; 45(6):349–357. doi: 10.1002/lsm.22153
Jackson RF, Roche GC, Shanks SC. A double-blind, placebo-controlled randomized trial evaluating the ability of low-level laser therapy to improve the appearance of cellulite. Lasers Surg Med. 2013; 45(3):141–147. doi: 10.1002/lsm.22119.
McRae E, Boris J. Independent evaluation of low-level laser therapy at 635 nm for non-invasive body contouring of the waist, hips, and thighs. Lasers Surg Med. 2013;45(1):1–7. doi: 10.1002/lsm.22113.
Caruso-Davis MK, Guillot TS, Podichetty VK, Mashtalir N, Dhurandhar NV, Dubuisson O et al. Efficacy of low-level laser therapy for body contouring and spot fat reduction. Obes Surg. 2011; 21(6):722–729. doi: 10.1007/s11695-010-0126-y.
Jackson RF, Stern FA, Neira R, Ortiz-Neira CL, Maloney J. Application of low-level laser therapy for noninvasive body contouring. Lasers Surg Med. 2012; 44(3):211–217. doi: 10.1002/lsm.22007.
Pelkman CL, Fishell VK, Maddox DH, Pearson TA, Mauger DT, Kris-Etherton PM. Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women. Am J ClinNutr. 2004;79(2):204-12. doi: 10.1002/lsm.22007.
Gepner Y, Shelef I, Komy O, Cohen N, Schwarzfuchs D, Bril N et al. The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content, J Hepatol. 2019;71(2):379-388. doi: 10.1016/j.jhep.2019.04.013.
Moosavian S , Arab A, Paknahad Z. The effect of a Mediterranean diet on metabolic parameters in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. Clin Nutr ESPEN. 2020;35:40-46. doi:10.1016/j.clnesp.2019.10.008
- Abstract Viewed: 843 times
- PDF Downloaded: 496 times